Cargando…
Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent NTRK gene fusions
Glioneuronal tumors are a heterogenous group of CNS neoplasms that can be challenging to accurately diagnose. Molecular methods are highly useful in classifying these tumors—distinguishing precise classes from their histological mimics and identifying previously unrecognized types of tumors. Using a...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10119244/ https://www.ncbi.nlm.nih.gov/pubmed/36933012 http://dx.doi.org/10.1007/s00401-023-02558-0 |
_version_ | 1785028983793909760 |
---|---|
author | Bogumil, Henri Sill, Martin Schrimpf, Daniel Ismer, Britta Blume, Christina Rahmanzade, Ramin Hinz, Felix Cherkezov, Asan Banan, Rouzbeh Friedel, Dennis Reuss, David E. Selt, Florian Ecker, Jonas Milde, Till Pajtler, Kristian W. Schittenhelm, Jens Hench, Jürgen Frank, Stephan Boldt, Henning B. Kristensen, Bjarne Winther Scheie, David Melchior, Linea C. Olesen, Viola Sehested, Astrid Boué, Daniel R. Abdullaev, Zied Satgunaseelan, Laveniya Kurth, Ina Seidlitz, Annekatrin White, Christine L. Ng, Ho-Keung Shi, Zhi-Feng Haberler, Christine Deckert, Martina Timmer, Marco Goldbrunner, Roland Tauziède-Espariat, Arnault Varlet, Pascale Brandner, Sebastian Alexandrescu, Sanda Snuderl, Matija Aldape, Kenneth Korshunov, Andrey Witt, Olaf Herold-Mende, Christel Unterberg, Andreas Wick, Wolfgang Pfister, Stefan M. von Deimling, Andreas Jones, David T. W. Sahm, Felix Sievers, Philipp |
author_facet | Bogumil, Henri Sill, Martin Schrimpf, Daniel Ismer, Britta Blume, Christina Rahmanzade, Ramin Hinz, Felix Cherkezov, Asan Banan, Rouzbeh Friedel, Dennis Reuss, David E. Selt, Florian Ecker, Jonas Milde, Till Pajtler, Kristian W. Schittenhelm, Jens Hench, Jürgen Frank, Stephan Boldt, Henning B. Kristensen, Bjarne Winther Scheie, David Melchior, Linea C. Olesen, Viola Sehested, Astrid Boué, Daniel R. Abdullaev, Zied Satgunaseelan, Laveniya Kurth, Ina Seidlitz, Annekatrin White, Christine L. Ng, Ho-Keung Shi, Zhi-Feng Haberler, Christine Deckert, Martina Timmer, Marco Goldbrunner, Roland Tauziède-Espariat, Arnault Varlet, Pascale Brandner, Sebastian Alexandrescu, Sanda Snuderl, Matija Aldape, Kenneth Korshunov, Andrey Witt, Olaf Herold-Mende, Christel Unterberg, Andreas Wick, Wolfgang Pfister, Stefan M. von Deimling, Andreas Jones, David T. W. Sahm, Felix Sievers, Philipp |
author_sort | Bogumil, Henri |
collection | PubMed |
description | Glioneuronal tumors are a heterogenous group of CNS neoplasms that can be challenging to accurately diagnose. Molecular methods are highly useful in classifying these tumors—distinguishing precise classes from their histological mimics and identifying previously unrecognized types of tumors. Using an unsupervised visualization approach of DNA methylation data, we identified a novel group of tumors (n = 20) that formed a cluster separate from all established CNS tumor types. Molecular analyses revealed ATRX alterations (in 16/16 cases by DNA sequencing and/or immunohistochemistry) as well as potentially targetable gene fusions involving receptor tyrosine-kinases (RTK; mostly NTRK1-3) in all of these tumors (16/16; 100%). In addition, copy number profiling showed homozygous deletions of CDKN2A/B in 55% of cases. Histological and immunohistochemical investigations revealed glioneuronal tumors with isomorphic, round and often condensed nuclei, perinuclear clearing, high mitotic activity and microvascular proliferation. Tumors were mainly located supratentorially (84%) and occurred in patients with a median age of 19 years. Survival data were limited (n = 18) but point towards a more aggressive biology as compared to other glioneuronal tumors (median progression-free survival 12.5 months). Given their molecular characteristics in addition to anaplastic features, we suggest the term glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA) to describe these tumors. In summary, our findings highlight a novel type of glioneuronal tumor driven by different RTK fusions accompanied by recurrent alterations in ATRX and homozygous deletions of CDKN2A/B. Targeted approaches such as NTRK inhibition might represent a therapeutic option for patients suffering from these tumors. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00401-023-02558-0. |
format | Online Article Text |
id | pubmed-10119244 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-101192442023-04-22 Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent NTRK gene fusions Bogumil, Henri Sill, Martin Schrimpf, Daniel Ismer, Britta Blume, Christina Rahmanzade, Ramin Hinz, Felix Cherkezov, Asan Banan, Rouzbeh Friedel, Dennis Reuss, David E. Selt, Florian Ecker, Jonas Milde, Till Pajtler, Kristian W. Schittenhelm, Jens Hench, Jürgen Frank, Stephan Boldt, Henning B. Kristensen, Bjarne Winther Scheie, David Melchior, Linea C. Olesen, Viola Sehested, Astrid Boué, Daniel R. Abdullaev, Zied Satgunaseelan, Laveniya Kurth, Ina Seidlitz, Annekatrin White, Christine L. Ng, Ho-Keung Shi, Zhi-Feng Haberler, Christine Deckert, Martina Timmer, Marco Goldbrunner, Roland Tauziède-Espariat, Arnault Varlet, Pascale Brandner, Sebastian Alexandrescu, Sanda Snuderl, Matija Aldape, Kenneth Korshunov, Andrey Witt, Olaf Herold-Mende, Christel Unterberg, Andreas Wick, Wolfgang Pfister, Stefan M. von Deimling, Andreas Jones, David T. W. Sahm, Felix Sievers, Philipp Acta Neuropathol Original Paper Glioneuronal tumors are a heterogenous group of CNS neoplasms that can be challenging to accurately diagnose. Molecular methods are highly useful in classifying these tumors—distinguishing precise classes from their histological mimics and identifying previously unrecognized types of tumors. Using an unsupervised visualization approach of DNA methylation data, we identified a novel group of tumors (n = 20) that formed a cluster separate from all established CNS tumor types. Molecular analyses revealed ATRX alterations (in 16/16 cases by DNA sequencing and/or immunohistochemistry) as well as potentially targetable gene fusions involving receptor tyrosine-kinases (RTK; mostly NTRK1-3) in all of these tumors (16/16; 100%). In addition, copy number profiling showed homozygous deletions of CDKN2A/B in 55% of cases. Histological and immunohistochemical investigations revealed glioneuronal tumors with isomorphic, round and often condensed nuclei, perinuclear clearing, high mitotic activity and microvascular proliferation. Tumors were mainly located supratentorially (84%) and occurred in patients with a median age of 19 years. Survival data were limited (n = 18) but point towards a more aggressive biology as compared to other glioneuronal tumors (median progression-free survival 12.5 months). Given their molecular characteristics in addition to anaplastic features, we suggest the term glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA) to describe these tumors. In summary, our findings highlight a novel type of glioneuronal tumor driven by different RTK fusions accompanied by recurrent alterations in ATRX and homozygous deletions of CDKN2A/B. Targeted approaches such as NTRK inhibition might represent a therapeutic option for patients suffering from these tumors. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00401-023-02558-0. Springer Berlin Heidelberg 2023-03-18 2023 /pmc/articles/PMC10119244/ /pubmed/36933012 http://dx.doi.org/10.1007/s00401-023-02558-0 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Paper Bogumil, Henri Sill, Martin Schrimpf, Daniel Ismer, Britta Blume, Christina Rahmanzade, Ramin Hinz, Felix Cherkezov, Asan Banan, Rouzbeh Friedel, Dennis Reuss, David E. Selt, Florian Ecker, Jonas Milde, Till Pajtler, Kristian W. Schittenhelm, Jens Hench, Jürgen Frank, Stephan Boldt, Henning B. Kristensen, Bjarne Winther Scheie, David Melchior, Linea C. Olesen, Viola Sehested, Astrid Boué, Daniel R. Abdullaev, Zied Satgunaseelan, Laveniya Kurth, Ina Seidlitz, Annekatrin White, Christine L. Ng, Ho-Keung Shi, Zhi-Feng Haberler, Christine Deckert, Martina Timmer, Marco Goldbrunner, Roland Tauziède-Espariat, Arnault Varlet, Pascale Brandner, Sebastian Alexandrescu, Sanda Snuderl, Matija Aldape, Kenneth Korshunov, Andrey Witt, Olaf Herold-Mende, Christel Unterberg, Andreas Wick, Wolfgang Pfister, Stefan M. von Deimling, Andreas Jones, David T. W. Sahm, Felix Sievers, Philipp Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent NTRK gene fusions |
title | Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent NTRK gene fusions |
title_full | Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent NTRK gene fusions |
title_fullStr | Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent NTRK gene fusions |
title_full_unstemmed | Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent NTRK gene fusions |
title_short | Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent NTRK gene fusions |
title_sort | glioneuronal tumor with atrx alteration, kinase fusion and anaplastic features (gtaka): a molecularly distinct brain tumor type with recurrent ntrk gene fusions |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10119244/ https://www.ncbi.nlm.nih.gov/pubmed/36933012 http://dx.doi.org/10.1007/s00401-023-02558-0 |
work_keys_str_mv | AT bogumilhenri glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions AT sillmartin glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions AT schrimpfdaniel glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions AT ismerbritta glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions AT blumechristina glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions AT rahmanzaderamin glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions AT hinzfelix glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions AT cherkezovasan glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions AT bananrouzbeh glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions AT friedeldennis glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions AT reussdavide glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions AT seltflorian glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions AT eckerjonas glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions AT mildetill glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions AT pajtlerkristianw glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions AT schittenhelmjens glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions AT henchjurgen glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions AT frankstephan glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions AT boldthenningb glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions AT kristensenbjarnewinther glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions AT scheiedavid glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions AT melchiorlineac glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions AT olesenviola glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions AT sehestedastrid glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions AT bouedanielr glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions AT abdullaevzied glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions AT satgunaseelanlaveniya glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions AT kurthina glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions AT seidlitzannekatrin glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions AT whitechristinel glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions AT nghokeung glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions AT shizhifeng glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions AT haberlerchristine glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions AT deckertmartina glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions AT timmermarco glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions AT goldbrunnerroland glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions AT tauziedeespariatarnault glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions AT varletpascale glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions AT brandnersebastian glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions AT alexandrescusanda glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions AT snuderlmatija glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions AT aldapekenneth glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions AT korshunovandrey glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions AT wittolaf glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions AT heroldmendechristel glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions AT unterbergandreas glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions AT wickwolfgang glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions AT pfisterstefanm glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions AT vondeimlingandreas glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions AT jonesdavidtw glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions AT sahmfelix glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions AT sieversphilipp glioneuronaltumorwithatrxalterationkinasefusionandanaplasticfeaturesgtakaamolecularlydistinctbraintumortypewithrecurrentntrkgenefusions |